Novo Nordisk said it plans to seek coverage by Germany's public health insurance scheme for the use of its Wegovy drug to cut the risk of strokes and heart attacks, if the drug's extended indication ...
Original Image Link
Source:www.reuters.com
Original Image Link
Source:www.reuters.com